Azelastine/Mometasone
氮卓斯汀/莫米松
Report date: 2022/01/17 12:14:22
Base Information
Drug NameAzelastine/Mometasone
Drug Alias Name +[17]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2012/11/16
Country/Territory
CombinationsYes Mometasone furoateAzelastine Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesHanmi Pharmaceutical Co LtdSandoz
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A